The FDA advisory panel voted to require dropsipirenone-containing birth control pills - including Yaz, Yasmin, and Ocella, to warn about increased risk of blood clots. Drospirenone has been linked to deep vein thrombosis, pulmonary embolism, stroke and heart attack. If you or a loved one has been affected and you need legal assistance, please call the number listed above, or complete the form to the right to receive a free legal evaluation.
Yaz Pulmonary Embolism Worries Patients
Yaz and Yasmin have been linked to a number of serious side effects and have recently become controversial because of this fact. Both of them are drospirenone-based fourth generation birth control pills that are manufactured by drug maker Bayer, and have become increasingly popular, especially among younger women. However, they have been associated with a number of blood-clot related side… Read more »
Illinois Yaz MDL Stay Extended for Third Time to Encourage Yaz Settlements
Trials in the Illinois Yaz MDL have been pushed back for the third time this year. On April 19, 2012, Chief Judge David R. Herndon (who is overseeing the MDL) once again ordered all pretrial deadlines pushed back 90 days. As before, he is urging the parties to try to reach settlements through mediation. The bellwether trials were originally scheduled… Read more »
Bayer Doles Out Millions to Yaz Litigants
Bayer, the drug maker behind the controversial drospirenone-based birth control medication Yaz, has allegedly set aside $110 million to deal with about 500 Yaz and Yasmin lawsuits coming from plaintiffs who have filed suit against the pharmaceuticals company after experiencing serious side effects, such as blood clots from Yaz and stroke from Yaz. These settlements are likely to be made… Read more »
Women’s Groups Protest FDA Decision to Keep Yaz on Market Despite Yaz Blood Clots
In the wake of an FDA panel’s vote to keep the controversial contraceptives Yaz and Yasmin on the market despite the known risk of blood clots from Yaz, four women’s groups sent a joint letter to FDA commissioner Margaret Hamburg disagreeing with the panel’s decision and expressing concern that it will put women’s health in jeopardy. According to an FDA-commissioned… Read more »
Generic Manufacturer Named in Yaz Lawsuit
A recent lawsuit alleging dangerous side effects of Yaz is including a generic drug maker as one of the defendants, even though the Supreme Court ruled last year that generic drug makers cannot be held accountable for not warning users about the side effects associated with their products. The plaintiff, Jeri Atkinson, filed her lawsuit with the help of a… Read more »
